• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测局部晚期直肠癌患者新辅助放化疗及根治性手术后远处转移的列线图。

A nomogram to predict distant metastasis after neoadjuvant chemoradiotherapy and radical surgery in patients with locally advanced rectal cancer.

作者信息

Sun Yanwu, Lin Huiming, Lu Xingrong, Huang Ying, Xu Zongbin, Huang Shenghui, Wang Xiaojie, Chi Pan

机构信息

Department of Colorectal Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, People's Republic of China.

出版信息

J Surg Oncol. 2017 Mar;115(4):462-469. doi: 10.1002/jso.24522. Epub 2017 Jan 20.

DOI:10.1002/jso.24522
PMID:28105657
Abstract

PURPOSE

To compare distant metastasis (DM) in locally advanced rectal cancer (LARC) patients treated with neoadjuvant chemoradiotherapy (nCRT) and surgery alone, and to develop a predictive nomogram for DM following nCRT.

METHODS

Propensity-scoring match analysis was performed to compare DM in LARC treated with nCRT (n = 375) and surgery alone (n = 375). Cox regression was performed to identify predictors of DM following nCRT. A nomogram was developed and validated by internal (n = 425) and external validation (n = 97).

RESULTS

The 5-year local recurrence rate was significantly lower in the nCRT group (5.6% vs. 10.4%; P = 0.020). The 5-year DM rates (nCRT vs. surgery alone: 25.3% vs. 24.4%; P = 0.235) were similar between groups. Cox regression showed that the post-nCRT pathologic stage (ypTNM stage, OR = 2.022, P = 0.002), IMA nodal metastasis (OR = 2.171, P = 0.023), and CRM involvement (OR = 2.535, P = 0.016) were independently associated with DM following nCRT. A predictive nomogram was developed with a C-index of 0.70 on internal validation, and 0.71 on the external validation.

CONCLUSION

NCRT improved local control, but not distant metastasis. A nomogram to predict 3- and 5-year DM rates, using clinicopathological parameters, was successfully developed. This prognostic tool could support decision-making in clinical practice and follow-up strategies.

摘要

目的

比较接受新辅助放化疗(nCRT)和单纯手术治疗的局部晚期直肠癌(LARC)患者的远处转移(DM)情况,并开发一种用于预测nCRT后DM的预测列线图。

方法

进行倾向评分匹配分析,以比较接受nCRT(n = 375)和单纯手术(n = 375)治疗的LARC患者的DM情况。进行Cox回归以确定nCRT后DM的预测因素。通过内部验证(n = 425)和外部验证(n = 97)开发并验证了列线图。

结果

nCRT组的5年局部复发率显著更低(5.6%对10.4%;P = 0.020)。两组之间的5年DM率相似(nCRT组对单纯手术组:25.3%对24.4%;P = 0.235)。Cox回归显示,nCRT后的病理分期(ypTNM分期,OR = 2.022,P = 0.002)、IMA淋巴结转移(OR = 2.171,P = 0.023)以及环周切缘受累情况(OR = 2.535,P = 0.016)与nCRT后的DM独立相关。开发了一种预测列线图,内部验证时C指数为0.70,外部验证时为0.71。

结论

nCRT改善了局部控制,但未改善远处转移。成功开发了一种使用临床病理参数预测3年和5年DM率的列线图。这种预后工具可支持临床实践中的决策制定和随访策略。

相似文献

1
A nomogram to predict distant metastasis after neoadjuvant chemoradiotherapy and radical surgery in patients with locally advanced rectal cancer.预测局部晚期直肠癌患者新辅助放化疗及根治性手术后远处转移的列线图。
J Surg Oncol. 2017 Mar;115(4):462-469. doi: 10.1002/jso.24522. Epub 2017 Jan 20.
2
Prognostic significance of neoadjuvant rectal score in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and construction of a prediction model.新辅助化疗放疗后局部进展期直肠癌新辅助直肠评分的预后意义及预测模型的构建
J Surg Oncol. 2018 Mar;117(4):737-744. doi: 10.1002/jso.24907. Epub 2017 Dec 11.
3
Is neoadjuvant chemoradiotherapy always necessary for mid/high local advanced rectal cancer: A comparative analysis after propensity score matching.新辅助放化疗对中/高位局部进展期直肠癌是否总是必要的:倾向评分匹配后的比较分析
Eur J Surg Oncol. 2017 Aug;43(8):1440-1446. doi: 10.1016/j.ejso.2017.04.007. Epub 2017 May 4.
4
Inferior mesenteric artery lymph node metastasis in rectal cancer treated with neoadjuvant chemoradiotherapy: Incidence, prediction and prognostic impact.新辅助放化疗治疗直肠癌时肠系膜下动脉淋巴结转移:发生率、预测及预后影响
Eur J Surg Oncol. 2017 Jan;43(1):85-91. doi: 10.1016/j.ejso.2016.09.005. Epub 2016 Sep 24.
5
Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.与新辅助长疗程放化疗相比,术前序贯短疗程放疗联合FOLFOX化疗改善直肠癌患者的转移和无病生存率:配对分析结果
Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):417-426. doi: 10.1016/j.ijrobp.2017.05.048. Epub 2017 Jun 6.
6
Pathological complete response may underestimate distant metastasis in locally advanced rectal cancer following neoadjuvant chemoradiotherapy and radical surgery: Incidence, metastatic pattern, and risk factors.新辅助放化疗和根治性手术后局部晚期直肠癌的病理完全缓解可能低估远处转移:发生率、转移模式和危险因素。
Eur J Surg Oncol. 2019 Jul;45(7):1225-1231. doi: 10.1016/j.ejso.2019.03.005. Epub 2019 Mar 9.
7
[Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].局部晚期直肠癌患者新辅助治疗与全新辅助治疗的短期疗效及围手术期安全性比较
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):274-280. doi: 10.3760/cma.j.cn.441530-20190819-00312.
8
A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.用于预测局部晚期直肠癌新辅助放化疗后淋巴结阳性的列线图
Dis Colon Rectum. 2016 Aug;59(8):710-7. doi: 10.1097/DCR.0000000000000638.
9
Deep learning radiomics-based prediction of distant metastasis in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A multicentre study.深度学习影像组学预测新辅助放化疗后局部进展期直肠癌患者远处转移:一项多中心研究。
EBioMedicine. 2021 Jul;69:103442. doi: 10.1016/j.ebiom.2021.103442. Epub 2021 Jun 20.
10
Pretreatment MRI-detected extramural venous invasion as a prognostic and predictive biomarker for neoadjuvant chemoradiotherapy in non-metastatic rectal cancer: a propensity score matched analysis.治疗前MRI检测到的壁外静脉侵犯作为非转移性直肠癌新辅助放化疗的预后和预测生物标志物:一项倾向评分匹配分析
Eur Radiol. 2024 Jun;34(6):3686-3698. doi: 10.1007/s00330-023-10300-3. Epub 2023 Nov 23.

引用本文的文献

1
Artificial Intelligence and Rectal Cancer: Beyond Images.人工智能与直肠癌:超越图像
Cancers (Basel). 2025 Jul 3;17(13):2235. doi: 10.3390/cancers17132235.
2
Efficacies of radiotherapy in rectal cancer patients treated with total mesorectal excision or other types of surgery: an updated meta-analysis.全直肠系膜切除术或其他类型手术治疗的直肠癌患者中放疗的疗效:一项更新的荟萃分析。
Oncol Rev. 2025 May 1;19:1567818. doi: 10.3389/or.2025.1567818. eCollection 2025.
3
Radiomics in rectal cancer: current status of use and advances in research.
直肠癌中的放射组学:应用现状与研究进展
Front Oncol. 2025 Jan 17;14:1470824. doi: 10.3389/fonc.2024.1470824. eCollection 2024.
4
MRI-based radiomic nomogram for predicting disease-free survival in patients with locally advanced rectal cancer.基于磁共振成像的影像组学列线图预测局部晚期直肠癌患者的无病生存期
Abdom Radiol (NY). 2025 Jun;50(6):2388-2400. doi: 10.1007/s00261-024-04710-0. Epub 2024 Dec 4.
5
Age-related differences in progression patterns, follow-up strategies, and postoperative outcomes in locally advanced rectal cancer: insights from a large-scale validated study.局部晚期直肠癌进展模式、随访策略及术后结局的年龄相关差异:来自一项大规模验证性研究的见解
Ther Adv Med Oncol. 2024 Oct 17;16:17588359241290129. doi: 10.1177/17588359241290129. eCollection 2024.
6
Prediction by a multiparametric magnetic resonance imaging-based radiomics signature model of disease-free survival in patients with rectal cancer treated by surgery.基于多参数磁共振成像的影像组学特征模型对手术治疗的直肠癌患者无病生存期的预测
Front Oncol. 2024 Feb 22;14:1255438. doi: 10.3389/fonc.2024.1255438. eCollection 2024.
7
A refined prediction of early recurrence combining tumor deposits in patients with resected rectal mucinous adenocarcinoma.结合直肠黏液腺癌切除患者的肿瘤沉积物对早期复发进行精细化预测。
Surg Today. 2023 Jul;53(7):762-772. doi: 10.1007/s00595-022-02613-5. Epub 2022 Nov 11.
8
Development and external validation of prognostic nomograms for liver disease-free and overall survival in locally advanced rectal cancer with neoadjuvant therapy: a post cohort study based on the FOWARC trial.新辅助治疗的局部晚期直肠癌无肝病生存和总生存预后列线图的开发与外部验证:一项基于FOWARC试验的队列后研究
Ann Transl Med. 2022 Jun;10(12):694. doi: 10.21037/atm-22-2790.
9
A Predictive Model of 2yDFS During MR-Guided RT Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.局部晚期直肠癌患者磁共振引导下放疗新辅助放化疗期间2年无病生存的预测模型
Front Oncol. 2022 Feb 24;12:831712. doi: 10.3389/fonc.2022.831712. eCollection 2022.
10
Nomogram to Predict the Overall Survival of Colorectal Cancer Patients: A Multicenter National Study.列线图预测结直肠癌患者总生存期:一项多中心全国性研究。
Int J Environ Res Public Health. 2021 Jul 21;18(15):7734. doi: 10.3390/ijerph18157734.